Form 4 holding
10%+ Owner
Eikon Therapeutics, Inc.
- Security class
- Common Stock
- Shares / value
- 4,312,139
- Estimated value
- Report date
- 06 Feb 2026
- Price
- Ownership
- By The Column Group IV, LP
Column Group IV GP, LP
Insider Reports History
- Location
- San Francisco, CA
- Signature
- /s/ The Column Group IV GP, LP, /s/ James Evangelista, Attorney-in-Fact
- All insider transactions
- Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date
Holdings reported by Column Group IV GP, LP:
Form 4 holding
10%+ Owner
Eikon Therapeutics, Inc.
- Security class
- Common Stock
- Shares / value
- 1,319,164
- Estimated value
- Report date
- 06 Feb 2026
- Price
- Ownership
- By The Column Group Opportunity III, LP
Form 4 holding
10%+ Owner
Eikon Therapeutics, Inc.
- Security class
- Common Stock
- Shares / value
- 148,840
- Estimated value
- Report date
- 06 Feb 2026
- Price
- Ownership
- By The Column Group IV-A, LP
Form 4 holding
10%+ Owner
Eikon Therapeutics, Inc.
- Security class
- Common Stock
- Shares / value
- 3,352
- Estimated value
- Report date
- 04 Feb 2026
- Price
- Ownership
- Indirect
Form 4 holding
10%+ Owner
Eikon Therapeutics, Inc.
- Security class
- Series A-1 Preferred Stock
- Shares / value
- 0
- Estimated value
- Report date
- 06 Feb 2026
- Price
- Ownership
- By The Column Group IV-A, LP
- Underlying class
- Common Stock
- Underlying amount
Form 4 holding
10%+ Owner
Eikon Therapeutics, Inc.
- Security class
- Series A-1 Preferred Stock
- Shares / value
- 0
- Estimated value
- Report date
- 06 Feb 2026
- Price
- Ownership
- By The Column Group IV, LP
- Underlying class
- Common Stock
- Underlying amount
Form 4 holding
10%+ Owner
Eikon Therapeutics, Inc.
- Security class
- Series A Preferred Stock
- Shares / value
- 0
- Estimated value
- Report date
- 06 Feb 2026
- Price
- Ownership
- By The Column Group IV-A, LP
- Underlying class
- Common Stock
- Underlying amount
Form 4 holding
10%+ Owner
Eikon Therapeutics, Inc.
- Security class
- Series A Preferred Stock
- Shares / value
- 0
- Estimated value
- Report date
- 06 Feb 2026
- Price
- Ownership
- By The Column Group IV, LP
- Underlying class
- Common Stock
- Underlying amount
Form 4 holding
10%+ Owner
Eikon Therapeutics, Inc.
- Security class
- Series C-1 Preferred Stock
- Shares / value
- 0
- Estimated value
- Report date
- 06 Feb 2026
- Price
- Ownership
- By The Column Group IV-A, LP
- Underlying class
- Common Stock
- Underlying amount
Form 4 holding
10%+ Owner
Eikon Therapeutics, Inc.
- Security class
- Series C-1 Preferred Stock
- Shares / value
- 0
- Estimated value
- Report date
- 06 Feb 2026
- Price
- Ownership
- By The Column Group IV, LP
- Underlying class
- Common Stock
- Underlying amount
Form 4 holding
10%+ Owner
Eikon Therapeutics, Inc.
- Security class
- Series D Preferred Stock
- Shares / value
- 0
- Estimated value
- Report date
- 06 Feb 2026
- Price
- Ownership
- By The Column Group Opportunity III, LP
- Underlying class
- Common Stock
- Underlying amount
Insider Reports Filed by Column Group IV GP, LP
4
EIKN
Eikon Therapeutics, Inc.
- Report period
- 06 Feb 2026
- Transactions
- 17
- Transaction value
- +$38,119,680
- Filing time
- 09 Feb 2026, 21:19
- Role
- 10%+ Owner
- Next action
- Open filing details
3
EIKN
Eikon Therapeutics, Inc.
- Report period
- 04 Feb 2026
- Transactions
- 0
- Transaction value
- $0
- Filing time
- 04 Feb 2026, 21:59
- Role
- 10%+ Owner
- Next action
- Open filing details